Interrogating the aged striatum: Robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration

Neurobiology of Disease

Volumn 77, Issue , 2015, Pages 191-203

  Collier, Timothy J ^a   O'Malley, Jennifer ^b   Rademacher, David J ^c   Stancati, Jennifer A ^a   Sisson, Kellie A ^a   Sortwell, Caryl E ^a   Paumier, Katrina L ^a   Gebremedhin, Kibrom G ^a   Steece Collier, Kathy ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c LAKE FOREST COLLEGE   (United States)

Author keywords

Aging; Dyskinesias; Grafting; Levodopa; Parkinson's disease; Rodent; Synaptopodin

Indexed keywords

LEVODOPA; AMPHETAMINE; FOSB PROTEIN, RAT; OXIDOPAMINE; PHOSPHOPROTEIN DARPP 32; PROTEIN C FOS; SUBSTANCE P;

ADULT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DYSKINESIA; EMBRYO; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MIDDLE AGED; NERVE FIBER GROWTH; NERVE TRANSPLANTATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; REINNERVATION; SHAM PROCEDURE; YOUNG ADULT; ANIMAL; CONVALESCENCE; DISEASE MODEL; FISCHER 344 RAT; HEMISPHERIC DOMINANCE; MAMMALIAN EMBRYO; METABOLISM; NEURITE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION;

AGING; AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; DOPAMINERGIC NEURONS; DYSKINESIA, DRUG-INDUCED; EMBRYO, MAMMALIAN; FUNCTIONAL LATERALITY; LEVODOPA; NEURITES; OXIDOPAMINE; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED F344; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; SUBSTANCE P;

EID: 84925446792     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.03.005     Document Type: Article

References (70)

1. Abbott A. Fetal-cell revival for Parkinson's. Nature 2014, 510:195-196.
2. Ambasudhan R., Dolatabadi N., Nutter A., Masliah E., Mckercher S.R., Lipton S.A. Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells. J. Comp. Neurol. 2014, 522:2845-2856.
3. Andersson M., Hibertson A., Cenci M.A. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 1999, 6:461-474.
4. Annett L.E., Torres E.M., Clarke D.J., Ishida Y., Barker R.A., Ridley R.M., Baker H.F., Dunnett S.B. Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age. Cell Transplant. 1997, 6:557-569.
5. Bakay R.A., Boyer K.L., Freed C.R., Ansari A.A. Immunological responses to injury and grafting in the central nervous system of nonhuman primates. Cell Transplant. 1998, 7:109-120.
6. Barker R.A., Barrett J., Mason S.L., Björklund A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol. 2013, 12:84-91.
7. Barnum C.J., Tansey M.G. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog. Brain Res. 2010, 184:113-132.
8. Battista D., Ganat Y., El Maarouf A., Studer L., Rutishauser U. Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice. Stem Cells Transl. Med. 2014, 3:108-113.
9. Bjorklund A., Kordower J.H. Cell therapy for Parkinson's disease: what next?. Mov. Disord. 2013, 28:110-115.
10. Breysse N., Carlsson T., Winkler C., Björklund A., Kirik D. The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease. J. Neurosci. 2007, 27:5849-5856.
11. Buttery P.C., Barker R.A. Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?. J. Comp. Neurol. 2014, 522:2802-2816.
12. Büchele F., Döbrössy M., Hackl C., Jiang W., Papazoglou A., Nikkhah G. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease. Neurobiol. Dis. 2014, 68:112-125.
13. Chermenina M., Schouten P., Nevalainen N., Johansson F., Orädd G., Strömberg I. GDNF is important for striatal organization and maintenance of dopamine neurons grown in the presence of the striatum. Neuroscience. 2014, 270:1-11.
14. Clarke D.J., Brundin P., Strecker R.E., Nilsson O.G., Bjorklund A., Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 1988, 73:115-126.
15. Collier T.J., Sortwell C.E., Dayley B.F. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J. Neurosci. 1999, 19:5563-5573.
16. Collier T.J., Dung Ling Z., Carvey P.M., Fletcher-Turner A., Yurek D.M., Sladek J.R., Kordower J.H. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp. Neurol. 2005, 191:S60-S70.
17. Collier T.J., Lipton J., Daley B.F., Palfi S., Chu Y., Sortwell C., Bakay R.A., Sladek J.R., Kordower J.H. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol. Dis. 2007, 26:56-65.
18. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 2006, 9:251-259.
19. Dickstein D.L., Weaver C.M., Luebke J.I., Hof P.R. Dendritic spine changes associated with normal aging. Neuroscience 2013, 251:21-32.
20. Evans J.R., Mason S.L., Barker R.A. Current status of clinical trials of neural transplantation in Parkinson's disease. Prog. Brain Res. 2012, 200:169-198.
21. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trajanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
22. Freeman T.B., Sanberg P.R., Nauert G.M., Boss B.D., Spector D., Olanow C.W., Kordower J.H. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 1995, 4:141-154.
23. Freund T.F., Bolam J.P., Bjorklund A., Stenevi U., Dunnett S.B., Powell J.F., Smith A.D. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci. 1985, 5:603-616.
24. Goren B., Kahveci N., Eyigor O., Alkan T., Korfali E., Ozluk K. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model. Surg. Neurol. 2005, 64:S33-S41.
25. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
26. Gundersen H.J., Bendtsen T.F., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sørensen F.B., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988, 96:379-394.
27. Hallett P.J., Cooper O., Sadi D., Robertson H., Mendez I., Isacson O. Long-term health of dopaminergic neuron transplants in Parkinson's disease patients. Cell Rep. 2014, 7:1755-1761.
28. Hickey P., Stacy M. AAV2-neurturin (CERE-120) for Parkinson's disease. Expert. Opin. Biol. Ther. 2013, 13:137-145.
29. Itzev D., Lolova I., Lolov S., Usunoff K.G. Age-related changes in the synapses of the rat's neostriatum. Arch. Physiol. Biochem. 2001, 109:80-89.
30. Itzev D.E., Lolov S.R., Usunoff K.G. Aging and synaptic changes in the paraventricular hypothalamic nucleus of the rat. Acta Physiol. Pharmacol. Bulg. 2003, 27:75-82.
31. Kefalopoulou Z., Aviles-Olmos I., Foltynie T. Critical aspects of clinical trial design for novel cell and gene therapies. Park. Dis. 2011, 804041.
32. Kefalopoulou Z., Politis M., Piccini P., Mencacci N., Bhatia K., Jahanshahi M., Widner H., Rehncrona S., Brundin P., Bjorklund A., Lindvall O., Limousin P., Quinn N., Foltynie T. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol. 2014, 71:83-87.
33. Kordower J.H., Chu Y., Stebbins G.T., De Kosky S.T., Cochran E.J., Bennett D., Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 2001, 49:202-213.
34. Kordower J.H., Bjorklund A. Trophic factor gene therapy for Parkinson's disease. Mov. Disord. 2013, 28:96-109.
35. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sandberg P.R., Hauser R.A., Smith D.A., Nauert G.M., Perl D.P., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 1995, 332:1118-1124.
36. Kordower J.H., Styren S., Clarke M., DeKosky S.T., Olanow C.W., Freeman T.B. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functioning fetal nigral implants. Cell Transplant. 1997, 6:213-219.
37. Kordower J.H., Olanow C.W., Dodiya H.B., Chu Y., Beach T.G., Adler C.H., Halliday G.M., Bartus R.T. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 2013, 136:2419-2431.
38. Larsen M., Bjarkam C.R., Østergaard K., West M.J., Sørensen J.C. The anatomy of the porcine subthalamic nucleus evaluated with immunohistochemistry and design-based stereology. Anat. Embryol. (Berl.) 2004, 208:239-247.
39. Lee C.S., Cenci M.A., Schulzer M., Björklund A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain 2000, 123:1365-1379.
40. Leranth C., Sladek J.R., Roth R.H., Redmond D.E. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals. Exp. Brain Res. 1998, 123:323-333.
41. Levine M.S., Adinolfi A.M., Fisher R.S., Hull C.D., Buchwald N.A., McAllister J.P. Quantitative morphology of medium-sized caudate spiny neurons in aged cats. Neurobiol. Aging 1986, 7:277-286.
42. Levine N.D., Rademacher D.J., Collier T.J., O'Malley J.A., Kells A.P., San Sebastian W., Bankiewicz K.S., Steece-Collier K. Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. J. Neurosci. Methods 2013, 213(2):214-227.
43. Ling Z.D., Collier T.J., Sortwell C.E., Lipton J.W., Vu T.Q., Robie H.C., Carvie P.M. Striatal trophic activity is reduced in the aged rat brain. Brain Res. 2000, 856:301-309.
44. Ma Y., Peng S., Dhawan V., Eidelberg D. Dopamine cell transplantation in Parkinson's disease: challenge and perspective. Br. Med. Bull. 2011, 100:173-189.
45. Mahalik T.J., Finger T.E., Stromberg I., Olson L. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J. Comp. Neurol. 1985, 240:60-70.
46. Maries E., Kordower J.H., Chu Y., Collier T.J., Sortwell C.E., Olaru E., Shannon K., Steece-Collier K. Focal but not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 2006, 21:165-180.
47. Matarredona E.R., Meyer M., Seiler R.W., Widmer H.R. CGP 3466 increases survival of cultured fetal dopaminergic neurons. Restor. Neurol. Neurosci. 2003, 21:19-37.
48. McNeill T.H., Brown S.A., Rafols J.A., Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 1998, 455:148-152.
49. Ouimet C.C., Langley-Gullion K.C., Greengard P. Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 1998, 808:8-12.
50. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, New York.
51. Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986.
52. Sama D.M., Norris C.M. Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction. Ageing Res. Rev. 2013, 12:982-995.
53. Santini E., Valjent E., Usiello A., Carta M., Borgkvist A., Girault J.A., Hervé D., Greengard P., Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. J. Neurosci. 2007, 27:6995-7005.
54. Segal M., Vlachos A., Korkotian E. The spine apparatus, synaptopodin, and dendritic spine plasticity. Neuroscientist 2010, 16(2):125-131. (Apr).
55. Sladek J.R., Collier T.J., Elsworth J.D., Roth R.H., Taylor J.R., Redmond D.E. Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates. Cell Transplant. 1998, 7:87-96.
56. Soderstrom K.E., Meredith G., Freeman T.B., McGuire S.O., Collier T.J., Sortwell C.E., Wu Q., Steece-Collier K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol. Dis. 2008, 32:229-242.
57. Soderstrom K.E., O'Malley J.A., Levine N.D., Sortwell C.E., Collier T.J., Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur. J. Neurosci. 2010, 31:478-490.
58. Sortwell C.E., Camargo M.D., Pitzer M.R., Gyawali S., Collier T.J. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 2001, 169(1):23-29.
59. Steece-Collier K., Collier T.J., Sladek J.R. Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Exp. Neurol. 1990, 110:201-208.
60. Steece-Collier K., Yurek D.M., Collier T.J., Junn F.S., Sladek J.R. The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing. Brain Res. 1995, 676:404-408.
61. Steece-Collier K., Collier T.J., Danielson P.D., Kurlan R., Yurek D.M., Sladek J.R. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats. Mov. Disord. 2003, 18:1442-1454.
62. Steece-Collier K., Rademacher D.J., Soderstrom K. Anatomy of graft-induced dyskinesias: circuit remodeling in the parkinsonian striatum. Basal Ganglia 2012, 2:15-30.
63. Strömberg I., Bygdeman M., Goldstein M., Seiger A., Olson L. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation. Neurosci. Lett. 1986, 71:271-276.
64. Sundberg M., Isacson O. Advances in stem cell-generated transplantation therapy for Parkinson's disease. Expert. Opin. Biol. Ther. 2014, 14:437-453.
65. Terpstra B.T., Collier T.J., Marchionini D.M., Levine N.D., Paumier K.L., Sortwell C.E. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons. J. Neurosci. Methods 2007, 166:13-19.
66. Thompson V.B., Koprich J.B., Chen E.Y., Kordower J.H., Terpstra B.T., Lipton J.W. Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat. Neurotoxicol. Teratol. 2012, 34:206-213.
67. Torres E.M., Monville C., Gates M.A., Bagga V., Dunnett S.B. Improved survival of young donor age dopamine grafts in a rat model of. Park. Dis. 2007, 146(4):1606-1617.
68. Vlachos A., Korkotian E., Schonfeld E., Copanaki E., Deller T., Segal M. Synaptopodin regulates plasticity of dendritic spines in hippocampal neurons. J. Neurosci. 2009, 29(4):1017-1033.
69. Winkler C., Georgievska B., Carlsson T., Lacar B., Kirik D. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats. Neuroscience 2006, 141:521-531.
70. Zhang Y., Meredith G.E., Mendoza-Elias N., Rademacher D.J., Tseng K.Y., Steece-Collier K. Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses. J. Neurosci. 2013, 33:11655-11667.